rasburicase, an antineoplastic antimetabolite used to reduce uric acid levels in children with leukemia or lymphoma and in chemotherapy patients with solid tumor malignancies.
rasburicase, an antineoplastic antimetabolite used to reduce uric acid levels in children with leukemia or lymphoma and in chemotherapy patients with solid tumor malignancies.